國家衛生研究院 NHRI:Item 3990099045/3330

NHRI > Institute of Biotechnology and Pharmaceutical Research > Hsing-Pang Hsieh > Periodical Articles > Item 3990099045/3330

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/3330

Title:	Antiviral drug discovery against SARS-CoV
Authors:	Wu, YS;Lin, WH;Hsu, JTA;Hsieh, HP
Contributors:	Division of Biotechnology and Pharmaceutical Research
Abstract:	Severe Acute Respiratory Syndrome (SARS) is a life-threatening infectious disease caused by SARS-CoV. In the 2003 outbreak, it infected more than 8,000 people worldwide and claimed the lives of more than 900 victims. The high mortality rate resulted, at least in part, from the absence of definitive treatment protocols or therapeutic agents. Although the virus spreading has been contained, due preparedness and planning, including the successful development of antiviral drugs against SARS-CoV, is necessary for possible reappearance of SARS. In this review, we have discussed currently available strategies for antiviral drug discovery and how these technologies have been utilized to identify potential antiviral agents for the inhibition of SARS-CoV replication. Moreover, progress in the drug development based on different molecular targets is also summarized, including 1) Compounds that block the S protein-ACE2-mediated viral entry; 2) Compounds targeting SARS-CoV Mpro; 3) Compounds targeting papain-like protease 2 (PLP2); 4) Compounds targeting SARS-CoV RdRp; 5) Compounds targeting SARS-CoV helicase; 6) Active compounds with unspecified targets; and 7) Research on siRNA. This review aims to provide a comprehensive account of drug discovery on SARS. The experiences with the SARS outbreak and drug discovery would certainly be an important lesson for the drug development for any new viral outbreaks that may emerge in the future. 2006 Bentham Science Publishers Ltd.
Date:	2006-07
Relation:	Current Medicinal Chemistry. 2006 Jul;13(17):2003-2020.
Link to:	http://dx.doi.org/10.2174/092986706777584988
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0929-8673&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000207523900004
Cited Times(Scopus):	http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33745775497
Appears in Collections:	[Hsing-Pang Hsieh] Periodical Articles [John Tsu-An Hsu] Periodical Articles

Files in This Item:

File	Description	Size	Format
SCP33745775497.pdf		299Kb	Adobe PDF	350	View/Open

Loading...